Pregnancy temporarily alters a woman's immune system, making her more susceptible to malaria infection and less able to clear the parasite efficiently. In Nigeria, where transmission rates remain high, this creates a major public health challenge. The malaria parasite does not typically cross the placenta to infect the baby directly, but it attacks the placenta itself. Here, parasites sequester in the intervillous space, causing local inflammation and impairing the transfer of vital nutrients and oxygen from mother to foetus.
This placental damage triggers severe downstream complications. The most direct consequence is maternal anaemia, as the infection destroys red blood cells faster than the body can replace them. Furthermore, compromised placental function restricts foetal growth, leading frequently to low birth weight (LBW), which remains a leading cause of neonatal mortality across our health facilities. Premature delivery and stillbirth are also significantly more common when malaria goes untreated during pregnancy.
Understanding how *Plasmodium falciparum* behaves inside a pregnant woman helps explain why the clinical picture differs from non-pregnant adults. Infected erythrocytes develop adhesive knobs on their surfaces that bind to chondroitin sulfate A receptors located within the syncytiotrophoblast of the placenta. This allows the parasites to sequester heavily in the placental bed, out of reach of splenic clearance.
Primigravidae—women in their first pregnancy—suffer the most because their immune systems have never encountered these specific placental-binding variants before. Multigravidae women often possess pre-existing antibodies from previous pregnancies that clear these variants more swiftly.
The clinical presentation of malaria in pregnancy can sometimes be deceptive. While classic symptoms include high-grade intermittent fever, chills, severe headache, and joint pains, pregnant women—especially semi-immune adults in endemic regions—may present with subtle signs. A patient might only complain of general body weakness, dizziness, loss of appetite, or mild-to-moderate anaemia without a soaring temperature.
Midwives must maintain a high index of suspicion. Any pregnant woman presenting with vague malaise in an antenatal clinic should be evaluated for malaria. Severe malaria is a medical emergency characterized by prostration, impaired consciousness, jaundice, severe respiratory distress, or severe anaemia (packed cell volume below 20%). In busy Nigerian clinics, never dismiss a routine complaint of fatigue as normal pregnancy tiredness until malaria has been ruled out via rapid diagnostic tests (RDTs) or microscopy.
Prevention forms the bedrock of reducing the burden of malaria during pregnancy. In Nigeria, the National Malaria Elimination Programme outlines a comprehensive strategy centered on Intermittent Preventive Treatment in pregnancy (IPTp) and Insecticide-Treated Nets (ITNs).
Treating confirmed malaria in pregnancy requires prompt, decisive action to protect both mother and child. Uncomplicated malaria in the first trimester is treated with oral quinine plus clindamycin, because artemisinin-based combination therapies (ACTs) are traditionally avoided during the first twelve weeks due to theoretical safety concerns during organogenesis, though recent evidence suggests artemisinins can be used if no alternative exists. For uncomplicated malaria in the second and third trimesters, an approved ACT—such as Artemether-Lumefantrine—is the first-line treatment.
Severe malaria is a medical emergency requiring parenteral therapy regardless of gestational age. Intravenous artesunate is the gold standard, given for at least 24 hours until the patient can tolerate oral medication. Quinine infusion serves as an alternative if artesunate is unavailable. Supportive management—such as managing high body temperature with paracetamol, treating severe anaemia with blood transfusions, and monitoring fluid balance—is vital to prevent multi-organ failure.
Midwives and nurses play a central role in managing the recovery of pregnant women with malaria and preventing future episodes. Nursing care centers on rigorous monitoring of vital signs, tracking fluid intake and output, and watching closely for signs of worsening anaemia or foetal distress. Midwives should auscultate the foetal heart rate regularly to ensure the baby is tolerating the maternal illness well.
Education must focus on empowering the patient and her family. Teach mothers how to hang and tuck their insecticidal nets correctly every evening. Emphasize the importance of completing every single dose of prescribed antimalarial medication, even after fever subsides and energy returns. Finally, stress the value of attending all scheduled antenatal visits to receive timely doses of IPTp-SP and routine blood screening.